Research

Medical Sciences

Title :

An event-driven, phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficiency, safety, immunogenicity, & lot-to-lot consistency of Bbv152, a whole-varion inactivated Sars-Cov-2 vaccine in adults more than 18 to years of age

Area of research :

Medical Sciences

Focus area :

Task Force (TF)

Principal Investigator :

Mr. M. Shameem Professor ICMR-National Institute of Research In Tribal Health Madhya Pradesh

Timeline Start Year :

2020

Timeline End Year :

2021

Details

Total Budget (INR):

15,56,19,311

Organizations involved